Iradimed Net Income Applicable To Common Shares Over Time
| IRMD Stock | USD 42.50 0.27 0.63% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Iradimed Performance and Iradimed Correlation. Iradimed |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.185 | Dividend Share 0.15 | Earnings Share 1.4 | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.137 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Applicable To Common Shares Analysis
Compare Iradimed and related stocks such as Texas Pacific Land, RLI Corp, and Qudian Inc Net Income Applicable To Common Shares Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TPL | 3.8 M | 20.6 M | 19.6 M | 27.2 M | 34.8 M | 50 M | 37.2 M | 76.4 M | 209.7 M | 318.7 M | 176 M | 270 M | 446.4 M | 513.3 M | 539 M |
| RLI | 28.7 M | 130.6 M | 103.3 M | 126.3 M | 135.4 M | 137.5 M | 114.9 M | 105 M | 64.2 M | 191.6 M | 157.1 M | 279.4 M | 583.4 M | 670.9 M | 704.5 M |
| QD | (36.6 K) | (36.6 K) | (36.6 K) | (36.6 K) | (36.6 K) | (233.2 M) | 576.7 M | 2.2 B | 2.5 B | 3.3 B | 958.8 M | 589.1 M | (362 M) | (416.3 M) | (395.4 M) |
| TRNO | 2.4 M | 2.4 M | 2.4 M | 7.1 M | 7.1 M | 11 M | 11.6 M | 49.4 M | 62.9 M | 55.2 M | 79.4 M | 86.9 M | 197.2 M | 226.7 M | 238.1 M |
| PGR | 46.1 M | 1 B | 902.3 M | 1.2 B | 1.3 B | 1.3 B | 1 B | 1.6 B | 2.6 B | 3.9 B | 5.7 B | 3.3 B | 694.6 M | 798.8 M | 758.9 M |
| HGV | 167 M | 167 M | 167 M | 167 M | 167 M | 174 M | 168 M | 327 M | 298 M | 216 M | (201 M) | 176 M | 352 M | 316.8 M | 332.6 M |
| CNA | 1.2 B | 614 M | 628 M | 937 M | 691 M | 479 M | 859 M | 899 M | 813 M | 1000 M | 690 M | 1.2 B | 894 M | 1 B | 803 M |
| SMP | 10.2 M | 62.4 M | 41.4 M | 51.5 M | 43 M | 46 M | 60.4 M | 38 M | 43 M | 57.9 M | 57.4 M | 90.9 M | 55.4 M | 63.7 M | 39 M |
| COLD | (72 M) | (72 M) | (72 M) | (72 M) | (72 M) | (50.6 M) | (24.5 M) | (29.9 M) | 46.2 M | 48.2 M | 24.5 M | (30.5 M) | (19.4 M) | (22.4 M) | (23.5 M) |
Iradimed and related stocks such as Texas Pacific Land, RLI Corp, and Qudian Inc Net Income Applicable To Common Shares description
The net income that remains after preferred dividends have been deducted, available to common shareholders.My Equities
My Current Equities and Potential Positions
| Iradimed Co | IRMD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Florida; U.S.A |
| Exchange | NASDAQ Exchange |
USD 42.5
Additional Information and Resources on Investing in Iradimed Stock
When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:Check out Iradimed Performance and Iradimed Correlation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.